Serbia Pharmaceuticals & Healthcare Report Q1 2015 - New Report Available
The combination of a deteriorating economic outlook, rising political risks and industry-specific challenges place downside pressure on prospects for Serbia's pharmaceutical market. In light of this situation, we do not e xpect any meaningful investments by foreign firms. The key commercial opportunity is locally-made generic drugs.
View full press release